4.4 Article

Brief Cognitive and Behavioral Screening in Children With New-Onset Epilepsy: A Pilot Feasibility Trial

Journal

PEDIATRIC NEUROLOGY
Volume 52, Issue 1, Pages 49-55

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.pediatrneurol.2014.09.020

Keywords

computerized testing; neuropsychological comorbidity; epilepsy; executive function

Funding

  1. HRSA Project Access [H98MC26261-01-00]
  2. Epilepsy Foundation of Western/Central Pennsylvania
  3. Clinical Scientist Training Program of the University of Pittsburgh
  4. NIMH [2R25 MH054318]

Ask authors/readers for more resources

BACKGROUND: Minimal work has used psychometrically robust measures in a systematic fashion to identify and monitor children at risk for cognitive and behavioral comorbidities in current epilepsy care. We piloted a computerized cognitive battery and behavioral questionnaire for children with newly diagnosed epilepsy to determine clinical feasibility and acceptability to parents and patients. METHODS: We recruited medication-naive children (ages 8-17 years) with recent-onset seizures and typical developmental history from an outpatient child neurology clinic. Children completed the CNS Vital Signs computerized battery, whereas parents completed the Strengths and Difficulties Questionnaire. Post-test interviews with parents and patients were completed regarding the acceptability of the assessment procedures. RESULTS: Forty-four families were eligible, and 39 agreed to participate (89%). All assessments were completed in less than 45 minutes. Parents rated testing in clinic as convenient and important, expressing strong interest in the cognitive and behavioral impact of epilepsy and medication. Children also rated the testing procedure as acceptable and agreed that they would recommend it to peers. CONCLUSIONS: Our brief battery was tolerated and well received by children and their parents. Computerized testing of children along with a parent questionnaire is a psychometrically viable approach that is acceptable to families. Our protocol is time efficient for clinical use with the potential to detect early cognitive and behavioral difficulties related to epilepsy. Ongoing longitudinal study will provide further information regarding the success of our screening methods in monitoring for disease- or treatment-related changes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available